Cassandra Choe-Juliak

Cassandra Choe-Juliak, M.D., M.S. is a highly experienced medical professional currently serving as Chief Medical Officer at a Stealth Mode Biotechnology Company since June 2024 and as Medical Advisor at Mestag Therapeutics since May 2023. Additionally, Cassandra holds the position of Chief Medical Officer at TigaTx since February 2023 and previously at Remedy Plan Therapeutics from September 2023 to July 2024, as well as at Flame Biosciences from July 2021 to December 2022. Past roles include VP/Head of Clinical Development and Interim Chief Medical Officer at Affimed between July 2017 and July 2021, and Executive Medical Director at Karyopharm Therapeutics Inc. from May 2015 to June 2017. Cassandra’s career also includes significant positions at Ipsen, Merck, and AVEO Oncology, showcasing a robust background in oncology and clinical research. Educational credentials include a Doctor of Medicine from Virginia Commonwealth University School of Medicine, a Master of Science in Pharmacology & Toxicology from the same institution, and a Bachelor of Arts in Economics with Pre-Medicine from Georgetown University.